Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300).
Gugliandolo SG, Marvaso G, Comi S, Pepa M, Romanò C, Zerini D, Augugliaro M, Russo S, Vischioni B, Valvo F, Giandini T, Avuzzi B, Valdagni R, Ciardo D, De Cobelli O, Jereczek-Fossa BA, Cattani F, Orecchia R. Gugliandolo SG, et al. Among authors: ciardo d. Phys Med. 2020 Aug;76:327-336. doi: 10.1016/j.ejmp.2020.07.012. Epub 2020 Aug 2. Phys Med. 2020. PMID: 32750548
Set-up errors in head and neck cancer patients treated with intensity modulated radiation therapy: Quantitative comparison between three-dimensional cone-beam CT and two-dimensional kilovoltage images.
Ciardo D, Alterio D, Jereczek-Fossa BA, Riboldi M, Zerini D, Santoro L, Preve E, Rondi E, Comi S, Serafini F, Laudati A, Ansarin M, Preda L, Baroni G, Orecchia R. Ciardo D, et al. Phys Med. 2015 Dec;31(8):1015-1021. doi: 10.1016/j.ejmp.2015.08.004. Epub 2015 Oct 12. Phys Med. 2015. PMID: 26459318
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy.
Jereczek-Fossa BA, Ciardo D, Ferrario S, Fossati P, Fanetti G, Zerini D, Zannoni D, Fodor C, Gerardi MA, Surgo A, Muto M, Cambria R, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: ciardo d. Br J Radiol. 2016 Jul;89(1063):20150985. doi: 10.1259/bjr.20150985. Epub 2016 Apr 25. Br J Radiol. 2016. PMID: 27109736 Free PMC article.
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.
Timon G, Ciardo D, Bazani A, Garioni M, Maestri D, De Lorenzo D, Pansini F, Cambria R, Rondi E, Cattani F, Marvaso G, Zerini D, Vischioni B, Ciocca M, Russo S, Molinelli S, Golino F, Scroffi V, Rojas DP, Fodor C, Petralia G, Santoro L, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: ciardo d. Tumori. 2016 Oct 13;102(5):536-540. doi: 10.5301/tj.5000547. Epub 2016 Aug 5. Tumori. 2016. PMID: 27514314 Clinical Trial.
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G, Jereczek-Fossa BA, Vischioni B, Ciardo D, Giandini T, Hasegawa A, Cattani F, Carrara M, Ciocca M, Bedini N, Villa S, Morlino S, Russo S, Zerini D, Colangione SP, Panaino CMV, Fodor C, Santoro L, Pignoli E, Valvo F, Valdagni R, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: ciardo d. Tumori. 2017 May 12;103(3):314-318. doi: 10.5301/tj.5000587. Epub 2016 Dec 2. Tumori. 2017. PMID: 28009421 Clinical Trial.
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach.
Marvaso G, Jereczek-Fossa BA, Riva G, Bassi C, Fodor C, Ciardo D, Cambria R, Pansini F, Zerini D, De Marco P, Cattani F, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: ciardo d. Clin Genitourin Cancer. 2017 Jun;15(3):376-383. doi: 10.1016/j.clgc.2017.01.007. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28190704 Clinical Trial.
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218.
Timon G, Ciardo D, Bazani A, Marvaso G, Riva G, Volpe S, Rojas DP, Renne G, Petralia G, Zerini D, Fodor C, Dicuonzo S, Maestri D, Pansini F, Cambria R, Cattani F, Golino F, Scroffi V, De Lorenzo D, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: ciardo d. Br J Radiol. 2018 Sep;91(1089):20160725. doi: 10.1259/bjr.20160725. Epub 2018 May 23. Br J Radiol. 2018. PMID: 29750539 Free PMC article. Clinical Trial.
83 results